Lumiliximab Biosimilar - Anti-CD23 Antibody - Low endotoxin, Azide free (A323562)

Recombinant chimeric monoclonal antibody to CD23 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Lumiliximab Biosimilar - Anti-CD23 Antibody - Low endotoxin, Azide free
Description
Recombinant chimeric monoclonal antibody to CD23.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Primate / Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 144.82 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
BLAST-2, C-type lectin domain family 4 member J, CD23A, CLEC4J, Fc-epsilon-RII, FCE2, FCER2, IGEBF, Immunoglobulin E-binding factor, Low affinity immunoglobulin epsilon Fc receptor, Lymphocyte IgE receptor
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Lumiliximab Biosimilar - Anti-CD23 Antibody - Low endotoxin, Azide free (A323562)? Please let us know so that we can list the citation on this page.

Alternative products to Lumiliximab Biosimilar - Anti-CD23 Antibody - Low endotoxin, Azide free (A323562)